KRAShing pancreatic cancer before takeoff.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41818383.
- Also identified by DOI 10.1126/science.aef6665.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Drugs that inhibit KRAS signaling delay the development of pancreatic cancer in mice.
Medical subject headings
- Pancreatic Neoplasms
- Proto-Oncogene Proteins p21(ras)
- Antineoplastic Agents
- Carcinoma, Pancreatic Ductal